The effectiveness and value of aducanumab for Alzheimer’s disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Detalles Bibliográficos
Autores principales: Synnott, Patricia G, Whittington, Melanie D, Lin, Grace A, Rind, David M, Pearson, Steven D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Perspectives on Value
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391229/
https://www.ncbi.nlm.nih.gov/pubmed/34714106
http://dx.doi.org/10.18553/jmcp.2021.27.11.1613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391229/
https://www.ncbi.nlm.nih.gov/pubmed/34714106
http://dx.doi.org/10.18553/jmcp.2021.27.11.1613

Ejemplares similares